Product
NanoDoce
Aliases
docetaxel; large surface area microparticle docetaxel
2 clinical trials
5 indications
Indication
Bladder CancerIndication
Urogenital NeoplasmsIndication
Urologic NeoplasmsIndication
Urologic CancerIndication
Bladder cancerClinical trial
Phase 1/2 Trial Evaluating the Safety and Tolerability of NanoDoce® Injection and Intravesical Instillation in Subjects With Urothelial CarcinomaStatus: Completed, Estimated PCD: 2021-11-02